The University of Oklahoma’s Master of Health Administration and Policy — the only MHA degree program offered in Oklahoma — has been reaccredited for a seven-year term by the Commission on Accreditation of Healthcare Management Education.

Yuri Lansinger, M.D., associate professor with the Department of Orthopedic Surgery at the University of Oklahoma College of Medicine and a board-certified orthopedic surgeon specializing in hand surgery, has received the Fulbright U.S. Scholar award for the 2024-2025 academic year.

A University of Oklahoma study about a “black box warning” for the asthma drug Singulair continues to influence a national conversation about the medication and its reported neuropsychiatric side effects in children and adolescents.

The University of Oklahoma has set a record for fundraising in a single day, raising $26,648,681 during Giving Day 2024. OU received nearly 7,100 gifts including support from all 50 states and 16 countries across the globe. OU’s annual Giving Day is the university's largest single fundraising event of the year, uniting the entire OU community to support students, departments and programs across all three OU campuses.

Like alien invaders in a sci-fi movie, pancreatic cancer cells quickly adapt to the weapons used against them and find ways to survive, even in the harshest of conditions. Understanding why is the aim of cancer scientists everywhere. A University of Oklahoma College of Medicine researcher recently advanced the knowledge of pancreatic cancer with a study about how it acclimates to and even thrives in a highly acidic environment. The research is published in the current issue of the journal Nature Cell Biology.